Viewing Study NCT05600920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-06-16 @ 11:15 PM
Study NCT ID: NCT05600920
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic CD4 Lymphopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Opportunistic Infections View
None Immunological Therapy View
None T-Cell Deficiency View
None Cytokine Therapy View